Skip to main content
. 2019 Oct 9;36(2):246–253. doi: 10.1007/s12288-019-01208-4

Table 4.

Criteria for systemic involvement in AL amyloidosis with appropriate investigations

System involved Criteria
Biopsy of affected or alternate site AND
Tests required to demonstrate systemic involvement
Renal Proteinuria of > 0.5 g/24 h (mainly albumin) 24 h urine protein
Cardiac involvement Lab or clinical evidence of involvement Echocardiography showing more than 12 mm wall thickness in absence of other causes

Echo

Troponin I

N terminal pro brain natriuretic peptide

ECG showing low voltage (< 5 mm) in all 12 leads

Liver

Liver span > 15 cm in absence of heart failure

Alkaline phosphatase > 1.5 times the normal range of lab

CT scan or radionuclide imaging

Alkaline phosphatase

Lung Radiographic evidence of diffuse interstitial lung disease is taken as evidence of amyloidosis CT scan/X ray
Gastro intestinal tract Biopsy evidence with amyloid